Browse Articles
Discover research articles across all indexed journals
Development of a novel postoperative adhesion induction model in cynomolgus monkeys with high reliability and reproducibility
Abstract Postoperative adhesions frequently occur following abdominal surgical interventions, leading to serious morbidities and requiring new therapeutic strategies. The development of new therapeutic agents to reduce postoperative adhesions needs animal models that closely mirror human pathophysiology. In this study, we established a novel surgical adhesion model in cynomolgus monkeys, which are characteristically similar to humans. Our model reliably and reproducibly developed adhesions. Histopathological analyses revealed that monkeys undergoing our novel surgery method exhibited changes consistent with those in monkeys that underwent open abdominal surgery. Furthermore, the cellular components of the adhesion tissue in our monkey model reflected those reported in human adhesion tissue. Furthermore, time-course transcriptomic analyses showed that our model accurately recapitulates the well-known progression cascade of postoperative adhesions. In addition, it identified the upregulation of gene that is absent in rodents. We expect our novel surgical method to be a promising tool for elucidating the detailed biology of postoperative adhesions and for assessing new therapeutic treatments with high translatability to human biology.
Four ways to power-up AI for drug discovery
Study on the robust control of higher-order networks
See snazzy slugs in all their luminous glory — February’s best science images
Investigation the effect of exchange solvents on the adsorption performances of Ce-MOFs towards organic dyes
US universities curtail PhD admissions amid Trump science funding cuts
Clinical characteristics and risk factors in pneumoconiosis patients with asthma
Shapley value-driven superior subset selection algorithm for carbon price interval forecast combination
Prediction of contrast-associated acute kidney injury with machine-learning in patients undergoing contrast-enhanced computed tomography in emergency department
Meet the ice-hunting robots headed for the Moon right now
Racism-related stress, health outcomes, substance use, and PrEP attitudes among Asian sexual minority men
Optimization and microstructural study of friction riveted carbon-Kevlar and aluminum joints for aerospace applications
Vesuvius volcano turned this brain to glass
RECENT DEVELOPMENTS IN QUERCETIN-LOADED NANOPARTICLES FOR CANCER TARGETING
Quercetin, a dietary polyphenol, has demonstrated anticancer properties across several malignancies, including pancreatic cancer, breast cancer, and melanoma. Quercetin is a naturally occurring bioflavonoid found in fruits, vegetables, seeds, berries, and tea. The cancer-preventive properties of quercetin are well established, attributed to its anti-inflammatory, anti-proliferative, and anti-angiogenic effects. Nonetheless, the inadequate water solubility and transport, chemical instability, brief half-life, and low bioavailability of quercetin restrict its therapeutic use in cancer chemoprevention. A comprehensive understanding of the molecular mechanisms governing controlled and regulated drug delivery is crucial for developing innovative and effective therapeutics. To surmount the accessibility constraints of quercetin, it may be administered as nano-conjugated quercetin. Nano-conjugated quercetin has garnered significant interest owing to its regulated drug release, prolonged retention in tumors, improved anticancer efficacy, and potential for therapeutic application. This paper presents an overview of quercetin's effects on cancer cells and the mechanisms behind these actions. We also examine the prospective usage of nanoparticles as nanocarriers in medicine delivery systems. This review can summarize the recent developments in quercetin-loaded Nanoparticles for Cancer treatment.
Construction of a prediction model for coronary heart disease in type 2 diabetes mellitus: a cross-sectional study
Daily briefing: An unvaccinated child is first US measles death in a decade
Scaling and networking a modular photonic quantum computer
Reply to: Causal claims, causal assumptions and protected area impact
Author Correction: High fatigue resistance in a titanium alloy via near-void-free 3D printing
POLYMERIC NANO-CARRIERS FOR DRUG DELIVERY SYSTEMS IN CANCER THERAPY - AN EXHAUSTIVE REVIEW
Progress in molecular pharmacology and a better comprehension of the mechanism of various diseases have necessitated the precise targeting of the cells responsible for initiating and advancing these diseases. This is particularly applicable to the majority of life-threatening illnesses that necessitate treatment medicines with multiple adverse effects. Therefore, precise tissue targeting is necessary to minimize systemic exposure. Modern drug delivery systems (DDS) are developed utilizing cutting-edge technology to expedite the administration of drugs across the body to a particular target area, optimizing the effectiveness of the treatment and reducing the buildup of drugs in unintended areas of the body. Consequently, they significantly impact the management and treatment of diseases. Modern drug delivery systems (DDS) provide significant advantages over traditional methods. These include improved performance, automation, precision, and efficacy. They consist of nanomaterials or miniaturized devices that comprise multifunctional components. These components are biocompatible, biodegradable, and possess high viscoelasticity, resulting in a longer circulating half-life. This article thoroughly examines the history and technological progress of medication delivery systems. The text provides an update on the latest advancements in drug delivery systems, including their therapeutic applications used in Cancer, their present obstacles, and potential future improvements for enhanced performance and utilization.